Pediatric Epiglottitis Medication
- Author: Robert W Tolan Jr, MD; Chief Editor: Russell W Steele, MD more...
Medication Summary
Antibiotic therapy is necessary in the management of epiglottitis but should be initiated after the airway is secured. Before obtaining culture results, use antibiotics for the most likely organisms. Following trauma to the epiglottis, Staphylococcus aureus should be suspected. With the presence of white patches, Candida albicans should be suspected. Sedation for comfort is also required.
Antibiotic agents
Class Summary
Initiate antibiotics to provide empiric coverage of the most likely bacterial pathogens in the context of the clinical setting. Treatment should continue for 7-10 days, in general.
Ceftriaxone (Rocephin)
Ceftriaxone is a third-generation cephalosporin antibiotic with broad-spectrum activity against gram-negative bacteria, including Haemophilus influenzae, Enterobacteriaceae, and Neisseria species, and variable activity against gram-positive bacteria. This agent binds to penicillin-binding proteins and inhibits the final transpeptidation step of peptidoglycan synthesis, resulting in cell wall destruction and death of the organism.
Cefotaxime (Claforan)
Cefotaxime is another third-generation cephalosporin antibiotic with broad-spectrum activity against gram-positive and gram-negative bacteria. This agent binds to penicillin-binding proteins and inhibits the final transpeptidation step of peptidoglycan synthesis, resulting in cell wall destruction and death of the organism.
Cefuroxime (Zinacef , Kefurox)
Cefuroxime is a second-generation cephalosporin antibiotic with activity against gram-positive and some gram-negative bacteria, including Haemophilus influenzae. Cefuroxime binds to penicillin-binding proteins and inhibits the final transpeptidation step of peptidoglycan synthesis, resulting in cell wall destruction and death of the organism.
Chloramphenicol
When combined with ampicillin, chloramphenicol is an alternative agent if cephalosporins are unable to be used. This agent elicits activity against some gram-positive, gram-negative, and anaerobic organisms by inhibiting protein synthesis via reversibly binding to the 50S ribosomal subunit. Although unavailable in the United States, this antibiotic remains in use in parts of the world.
Clindamycin (Cleocin)
Clindamycin is a semisynthetic antibiotic produced by the 7(S)-chloro-substitution of the 7(R)-hydroxyl group of the parent compound, lincomycin. It is useful for gram-positive infections, including most community-associated MRSA disease. This agent inhibits bacterial growth, possibly by blocking dissociation of peptidyl tRNA from ribosomes, causing RNA-dependent protein synthesis to arrest. Clindamycin widely distributes in the body without penetration of the central nervous system. This drug is protein bound and excreted by the liver and kidneys.
Ampicillin and sulbactam (Unasyn)
Ampicillin with sulbactam is the drug combination of a beta-lactamase inhibitor with ampicillin. This combination interferes with bacterial cell wall synthesis during active replication, causing bactericidal activity against susceptible organisms.
Ampicillin with sulbactam is used as an alternative to amoxicillin when the patient is unable to take medication orally. This combination covers skin, enteric flora, and anaerobes but is not ideal for nosocomial pathogens.
Rifampin (Rifadin)
Rifampin is used for chemoprophylaxis in Hib infections.
Analgesic-Antipyretics
Class Summary
Analgesic-antipyretic agents are helpful in relieving the lethargy, malaise, and fever associated with epiglottitis.
Acetaminophen (Tylenol, Acephen, Aspirin-Free Anacin)
Acetaminophen is the drug of choice (DOC) for treating pain in patients with documented hypersensitivity to aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs), those with upper gastrointestinal disease, or those who take oral anticoagulants. This agent reduces fever by a direct action on the hypothalamic heat-regulating centers, which increases dissipation of body heat via vasodilation and sweating.
Ibuprofen (NeoProfen, Advil, Motrin)
Ibuprofen is usually the DOC for treating mild to moderate pain, if no contraindications exist. This agent inhibits inflammatory reactions and pain, probably by decreasing the activity of the cyclooxygenase enzyme, which inhibits prostaglandin synthesis. Ibuprofen is one of the few nonsteroidal anti-inflammatory drugs (NSAIDs) indicated for fever reduction.
Vaccines, Inactivated (Bacterial)
Class Summary
These agents are used to induce active immunization against Haemophilus influenza type b.
Haemophilus b conjugate vaccine (ActHIB, Hiberix, PedvaxHIB)
This vaccine is used for routine immunization of children against invasive diseases caused by H influenzae type b by decreasing nasopharyngeal colonization. The CDC's Advisory Committee on Immunization Practices (ACIP) recommends that all children receive one of the conjugate vaccines licensed for infant use beginning routinely at age 2 months.
Kamienski M. When sore throat gets serious: three different cases, three very different causes. Am J Nurs. Oct 2007;107(10):35-8. [Medline].
Tebruegge M, Connell T, Kong K, Marks M, Curtis N. Necrotizing epiglottitis in an infant: an unusual first presentation of human immunodeficiency virus infection. Pediatr Infect Dis J. Feb 2009;28(2):164-6. [Medline].
Kong MS, Engel SH, Zalzal GH, Preciado D. Necrotizing epiglottitis and hemophagocytic lymphohistiocytosis. Int J Pediatr Otorhinolaryngol. Jan 2009;73(1):119-25. [Medline].
Adams WG, Deaver KA, Cochi SL, et al. Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. JAMA. Jan 13 1993;269(2):221-6. [Medline].
Frantz TD, Rasgon BM. Acute epiglottitis: changing epidemiologic patterns. Otolaryngol Head Neck Surg. Sep 1993;109(3 Pt 1):457-60. [Medline].
Faden H. The dramatic change in the epidemiology of pediatric epiglottitis. Pediatr Emerg Care. Jun 2006;22(6):443-4. [Medline].
Hopkins A, Lahiri T, Salerno R, Heath B. Changing epidemiology of life-threatening upper airway infections: the reemergence of bacterial tracheitis. Pediatrics. Oct 2006;118(4):1418-21. [Medline].
Guldfred LA, Lyhne D, Becker BC. Acute epiglottitis: epidemiology, clinical presentation, management and outcome. J Laryngol Otol. Aug 2008;122(8):818-23. [Medline].
Devlin B, Golchin K, Adair R. Paediatric airway emergencies in Northern Ireland, 1990-2003. J Laryngol Otol. Jul 2007;121(7):659-63. [Medline].
Kavanagh KR, Batti JS. Traumatic epiglottitis after foreign body ingestion. Int J Pediatr Otorhinolaryngol. Jun 2008;72(6):901-3. [Medline].
Ehara H. Tenderness over the hyoid bone can indicate epiglottitis in adults. J Am Board Fam Med. Sep-Oct 2006;19(5):517-20. [Medline].
Sobol SE, Zapata S. Epiglottitis and croup. Otolaryngol Clin North Am. Jun 2008;41(3):551-66, ix. [Medline].
Glynn F, Fenton JE. Diagnosis and management of supraglottitis (epiglottitis). Curr Infect Dis Rep. May 2008;10(3):200-4. [Medline].
Acevedo JL, Lander L, Choi S, Shah RK. Airway management in pediatric epiglottitis: a national perspective. Otolaryngol Head Neck Surg. Apr 2009;140(4):548-51. [Medline].
Alcaide ML, Bisno AL. Pharyngitis and epiglottitis. Infect Dis Clin North Am. Jun 2007;21(2):449-69, vii. [Medline].
Briem B, Thorvardsson O, Petersen H. Acute epiglottitis in Iceland 1983-2005. Auris Nasus Larynx. May 22 2008;[Medline].
Chiou CC, Seibel NL, Derito FA, Bulas D, Walsh TJ, Groll AH. Concomitant Candida epiglottitis and disseminated Varicella zoster virus infection associated with acute lymphoblastic leukemia. J Pediatr Hematol Oncol. Nov 2006;28(11):757-9. [Medline].
D'Agostino J. Pediatric airway nightmares. Emerg Med Clin North Am. Feb 2010;28(1):119-26. [Medline].
Duval M, Daniel SJ. Guillain-Barre syndrome presenting as epiglottitis in a child. Otolaryngol Head Neck Surg. Apr 2010;142(4):632-3. [Medline].
Jenkins IA, Saunders M. Infections of the airway. Paediatr Anaesth. Jul 2009;19 Suppl 1:118-30. [Medline].
Katori H, Tsukuda M. Acute epiglottitis: analysis of factors associated with airway intervention. J Laryngol Otol. Dec 2005;119(12):967-72. [Medline].
Martin S, Waters K, Perez MK, Kleman BT, Nield LS. Index of suspicion. Pediatr Rev. Mar 2009;30(3):107-13. [Medline].
Murphy TV, White KE, Pastor P, et al. Declining incidence of Haemophilus influenzae type b disease since introduction of vaccination. JAMA. Jan 13 1993;269(2):246-8. [Medline].
Nozicka CA, Naidu SH, McFadden J. Varicella-associated acute supraglottitis. Ann Emerg Med. Apr 1994;23(4):888-90. [Medline].
Rogers DJ, Sie KC, Manning SC. Epiglottitis due to nontypeable Haemophilus influenzae in a vaccinated child. Int J Pediatr Otorhinolaryngol. Feb 2010;74(2):218-20. [Medline].
Shah RK, Stocks C. Epiglottitis in the United States: national trends, variances, prognosis, and management. Laryngoscope. Jun 2010;120(6):1256-62. [Medline].
Shah S, Sharieff GQ. Pediatric respiratory infections. Emerg Med Clin North Am. Nov 2007;25(4):961-79, vi. [Medline].

